Diseases, Conditions, Syndromes

Nurse intervention using tech may improve PID care in youth

Adolescent and young adult women with pelvic inflammatory disease (PID) are more likely to experience decreases in Neisseria gonorrhoeae and Chlamydia trachomatis positivity with a technology-enhanced community health nursing ...

Diseases, Conditions, Syndromes

Gonorrhoea cases on the rise across Europe

Following a decline in notification rates in 2016, the number of gonorrhoea cases has gone up by 17% across the reporting EU/EEA countries with more than 89 000 confirmed diagnoses in 2017—more than 240 cases a day.

Diseases, Conditions, Syndromes

Drug-resistance of gonorrhea in the EU: persistent but stable

Neisseria gonorrhoea continues to show high levels of resistance to azithromycin across the European Union and European Economic Area, according to the 2016 results of the European Gonococcal Antimicrobial Surveillance Programme ...

Diseases, Conditions, Syndromes

Infectious diseases treated on the spot

Point-of-care testing developed at Flinders University will be part of the rollout of new services targeting infectious diseases across remote Australia and also the Asia-Pacific.

page 1 from 5

Gonorrhea

Gonorrhea (also colloquially known as the clap) is a common sexually transmitted infection caused by the bacterium Neisseria gonorrhoeae. The usual symptoms in men are burning with urination and penile discharge. Women, on the other hand, are asymptomatic half the time or have vaginal discharge and pelvic pain. In both men and women if gonorrhea is left untreated, it may spread locally causing epididymitis or pelvic inflammatory disease or throughout the body, affecting joints and heart valves.

Treatment is commonly with ceftriaxone as antibiotic resistance has developed to many previously used medications.

In 2011, there were reports of some strains of gonorrhea showing resistance to ceftriaxone.

This text uses material from Wikipedia, licensed under CC BY-SA